The Diabetic Kidney
Although diabetic kidney disease is the most prevalent cause of end-stage renal disease and the disease most often leading to chronic renal replacement therapy and kidney transplantation, there has been, in recent years, a steady increase in basic and clinical knowledge of the problem. In The Diabet...
שמור ב:
| מחבר תאגידי: | |
|---|---|
| מחברים אחרים: | |
| פורמט: | אלקטרוני ספר אלקטרוני |
| שפה: | English |
| יצא לאור: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2006.
|
| מהדורה: | 1st ed. 2006. |
| סדרה: | Contemporary Diabetes,
|
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/978-1-59745-153-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
תוכן הענינים:
- Basic Pathophysiology and Biochemistry of Diabetic Nephropathy
- Angiotensin II and Its Receptors in the Pathogenesis of Diabetic Nephropathy
- Altered Renal Microvascular Function in Early Diabetes
- Proteinuria and Interstitial Fibrogenesis in Diabetic Nephropathy
- Podocytes and Diabetic Nephropathy
- Altered Glucose Transport and Its Metabolic Effects in Glomerular Cells
- mRNA Translation in Diabetic Nephropathy
- The Hexosamine Biosynthesis Pathway
- Glycation
- Oxidative and Glycooxidative Stress in Diabetic Nephropathy
- Connective Tissue Growth Factor in the Pathogenesis of Diabetic Nephropathy
- Vascular Endothelial Growth Factor as a Determinant of Diabetic Nephropathy
- Transforming Growth Factor-? Signal Transduction in the Pathogenesis of Diabetic Nephropathy
- Hepatocyte Growth Factor
- Proteomics in the Investigation of Diabetic Nephropathy
- Gene Expression Profiling in the Investigation of Diabetic Nephropathy
- PPAR-? Ligands and Diabetic Nephropathy
- ?-Endosulfine in Diabetic Nephropathy
- The Prospect of a Novel Therapeutic, Bone Morphogenetic Protein-7, in Diabetic Nephropathy
- Clinical Aspects of Diabetic Nephropathy
- Genetic Determinants of Diabetic Nephropathy in Type 2 Diabetes
- Major Risks Indicators for Diabetic Kidney Disease
- The Structure of Human Diabetic Nephropathy
- Diabetic Kidney Disease in Transitional and Disadvantaged Populations
- Screening and Treatment of Early Diabetic Renal Disease in Type 1 and Type 2 Diabetes
- Treatment in Advanced Renal Disease in Type 1 and Type 2 Diabetes
- Diabetic Renal and Related Heart Disease
- Management of Diabetic End-Stage Renal Disease With Dialysis
- Diabetic Retinopathy and Nephropathy
- Hypertension and Cardiovascular Disease
- Endothelial Dysfunction
- Anemia and Diabetic Nephropathy.